139 related articles for article (PubMed ID: 892911)
41. The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes.
Cohen S; Bernstein H; Hewes C; Chow M; Langer R
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10440-4. PubMed ID: 1961708
[TBL] [Abstract][Full Text] [Related]
42. Immune response of the hamster to oral and parenteral immunization.
Dolezel J; Bienenstock J
Cell Immunol; 1971 Aug; 2(4):326-34. PubMed ID: 4942637
[No Abstract] [Full Text] [Related]
43. Using procedure of emulsification-lyophilization to form lipid A-incorporating cochleates as an effective oral mucosal vaccine adjuvant-delivery system (VADS).
Wang N; Wang T; Zhang M; Chen R; Deng Y
Int J Pharm; 2014 Jul; 468(1-2):39-49. PubMed ID: 24704308
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of ethylene-vinyl acetate copolymer as a non-inflammatory alternative to Freund's complete adjuvant in rabbits.
Niemi SM; Fox JG; Brown LR; Langer R
Lab Anim Sci; 1985 Dec; 35(6):609-12. PubMed ID: 4094398
[TBL] [Abstract][Full Text] [Related]
45. Mode of action of adjuvants: retinol and other lysosome-labilizing agents as adjuvants.
Spitznagel JK; Allison AC
J Immunol; 1970 Jan; 104(1):119-27. PubMed ID: 4903997
[No Abstract] [Full Text] [Related]
46. Immunoadjuvant activity of icariin that induces Th1-type antibody in mice.
Rhew KY; Han Y
Arch Pharm Res; 2012 Sep; 35(9):1685-91. PubMed ID: 23054726
[TBL] [Abstract][Full Text] [Related]
47. Influence of orally administered CpG-ODNs on the humoral response to bovine serum albumin (BSA) in chickens.
Ameiss KA; El Attrache J; Barri A; McElroy AP; Caldwell DJ
Vet Immunol Immunopathol; 2006 Apr; 110(3-4):257-67. PubMed ID: 16387368
[TBL] [Abstract][Full Text] [Related]
48. Investigation of 3-D ordered materials with a high adsorption capacity for BSA and their potential application as an oral vaccine adjuvant.
Zhang Q; Zhao Q; Zhang Y; Han N; Hu L; Zhang C; Jiang T; Wang S
J Colloid Interface Sci; 2014 Nov; 434():113-21. PubMed ID: 25170604
[TBL] [Abstract][Full Text] [Related]
49. Effect on systemic antibody concentrations of topical application of choleratoxin to skin of sheep.
Cope RB; Colditz IG
Aust Vet J; 2000 Feb; 78(2):121-3. PubMed ID: 10736674
[TBL] [Abstract][Full Text] [Related]
50. Chronic serum sickness in the rat: influence of antigen dose, route of antigen administration and strain of rat on the development of disease.
Noble B; Milgrom M; Van Liew JB; Brentjens JR
Clin Exp Immunol; 1981 Dec; 46(3):499-507. PubMed ID: 6461459
[TBL] [Abstract][Full Text] [Related]
51. The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice.
Morecki S; Nabet C; Falk P; Fridkis-Hareli M; Pecht I; Mond JJ; Slavin S
Autoimmunity; 1997; 25(4):223-32. PubMed ID: 9344330
[TBL] [Abstract][Full Text] [Related]
52. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
[TBL] [Abstract][Full Text] [Related]
53. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
Bomford R
Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
[TBL] [Abstract][Full Text] [Related]
54. Immune response to a mucosally administered aflatoxin B1 vaccine.
Wilkinson J; Rood D; Minior D; Guillard K; Darre M; Silbart LK
Poult Sci; 2003 Oct; 82(10):1565-72. PubMed ID: 14601734
[TBL] [Abstract][Full Text] [Related]
55. Importance of physical association between antigen and liposomes in liposomes adjuvanticity.
Thérien HM; Shahum E
Immunol Lett; 1989 Oct; 22(4):253-8. PubMed ID: 2628283
[TBL] [Abstract][Full Text] [Related]
56. Vitamin E adjuvant formulations in mice.
Tengerdy RP; Lacetera NG
Vaccine; 1991 Mar; 9(3):204-6. PubMed ID: 2042393
[TBL] [Abstract][Full Text] [Related]
57. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
[TBL] [Abstract][Full Text] [Related]
58. Specific suppression of immune response to a given antigen by emulsified oil droplets containing a mixture of antigen and dexamethasone phosphate.
Matuhasi T; Usui M
Nat New Biol; 1973 Oct; 245(146):213-5. PubMed ID: 4583614
[No Abstract] [Full Text] [Related]
59. Immunogenicity of bovine serum albumin and its oligopolymers in CBA mice.
Stark JM; Spitznagel JK
J Immunol; 1972 Mar; 108(3):800-6. PubMed ID: 5011757
[No Abstract] [Full Text] [Related]
60. Augmentation of antibody responses of mice to inhaled protein antigens by simultaneously inhaled bacterial lipopolysaccharides.
Mizoguchi K; Nakashima I; Hasegawa Y; Isobe K; Nagase F; Kawashima K; Shimokata K; Kato N
Immunobiology; 1986 Oct; 173(1):63-71. PubMed ID: 3542812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
